Proglumetacin

A non-steroidal anti-inflammatory drug

Proglumetacin
[[File:|frameless|220px|alt=|]]
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Overview

Proglumetacin is a non-steroidal anti-inflammatory drug (NSAID) used primarily for its analgesic and anti-inflammatory properties. It is a prodrug of indometacin, which means it is metabolized in the body to produce the active drug. Proglumetacin is often prescribed for the treatment of rheumatoid arthritis, osteoarthritis, and other inflammatory conditions.

Pharmacology

Proglumetacin is absorbed in the gastrointestinal tract and converted into its active form, indometacin, which inhibits the enzyme cyclooxygenase (COX). This inhibition reduces the synthesis of prostaglandins, compounds involved in inflammation, pain, and fever. By decreasing prostaglandin production, proglumetacin alleviates symptoms associated with inflammatory conditions.

Mechanism of Action

Chemical structure of Proglumetacin

Proglumetacin works by inhibiting both COX-1 and COX-2 enzymes. COX-1 is involved in maintaining the protective lining of the stomach, while COX-2 is more directly involved in the inflammatory response. The inhibition of these enzymes leads to reduced inflammation and pain, but can also result in gastrointestinal side effects due to decreased protection of the stomach lining.

Clinical Uses

Proglumetacin is used in the management of various inflammatory conditions, including:

• Rheumatoid arthritis
• Osteoarthritis
• Ankylosing spondylitis
• Acute musculoskeletal disorders

Side Effects

Common side effects of proglumetacin include gastrointestinal disturbances such as nausea, vomiting, and gastric ulcer formation. As with other NSAIDs, there is a risk of cardiovascular events and renal impairment with long-term use.

Contraindications

Proglumetacin should not be used in individuals with a history of peptic ulcer disease, gastrointestinal bleeding, or severe heart failure. It is also contraindicated in patients with known hypersensitivity to indometacin or other NSAIDs.

Related pages

• Non-steroidal anti-inflammatory drug
• Indometacin
• Cyclooxygenase